retatrutide trial A New Obesity Drug Delivered Surgery-Level Weight Loss in Clinical Trials Phase 2 Trial of Retatrutide

Pharmaceutical grade IGF-1 are not widely available and as a result, it should be noted that products claiming to contain IGF-1, may not actually contain IGF-1 at all, or may contain a very diluted form of the substance, or other potentially harmful substances

This is why many people who take traditional tablets feel like they aren't seeing the results they expected

Filed lawsuits allege that the manufacturers knew or should have known about their medications links to serious gastrointestinal disorders and have been accused of downplaying adverse events and failing to adequately warn doctors and patients of the dangers of their medications

mBio 8 , e00859-17 (2017)